ACAAI Paper Reviews Safety of Live Vaccines with Dupilumab
A new position paper from the American College of Allergy, Asthma & Immunology (ACAAI) addresses the safety of administering live vaccines to patients
Source: miragenews.com
Stay updated with breaking news from Expert Delphi Consensus Recommendation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new position paper from the American College of Allergy, Asthma & Immunology (ACAAI) addresses the safety of administering live vaccines to patients
A new position paper from the American College of Allergy, Asthma & Immunology (ACAAI) addresses the safety of administering live vaccines to patients who are currently being treated with dupilumab, a biologic therapy for various allergic conditions.